European research funders halt collaborations with China over data protection concerns
Major
European research funders
have paused collaborative projects with China, citing concerns over the country's Data Security Law, which restricts the sharing of 'important data' with overseas partners without approval. The suspension impacts joint research in fields like
health and environmental studies
, raising questions about the future of
international scientific cooperation
.
The impact of China's data security law
Implemented in 2021, China's Data Security Law broadly defines 'important data' as information that could threaten national or economic interests or affect the rights of individuals or organisations. European agencies, including the
German Research Foundation
, Swedish Research Council, and Swiss National Science Foundation, have expressed concerns over the law's vague provisions, which make it difficult to assess compliance and avoid legal liabilities.
The law requires security clearance from the Cyberspace Administration of China to export data classified as 'important,' effectively making cross-border
data sharing
extremely challenging. This has led to the suspension of new co-funded projects with China's National Natural Science Foundation.
Implications for global research
The halt in collaborations could delay progress in critical areas like pandemic response and air quality studies, where data sharing is essential. Experts warn that the restrictions may hinder the ability to address global health challenges effectively.
Jan Palmowski, Secretary-General of the Guild of European Research-Intensive Universities, emphasised the need for responsible and safe data sharing to tackle future pandemics and other health crises.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
2 days ago
- Indian Express
Private lunar lander from Japan crashes into moon in failed mission
A private lunar lander from Japan crashed while attempting a touchdown Friday, the latest casualty in the commercial rush to the moon. The Tokyo-based company ispace declared the mission a failure several hours after communication was lost with the lander. Flight controllers scrambled to gain contact, but were met with only silence and said they were concluding the mission. Communications ceased less than two minutes before the spacecraft's scheduled landing on the moon with a mini rover. Until then, the descent from lunar orbit seemed to be going well. CEO and founder Takeshi Hakamada apologized to everyone who contributed to the mission, the second lunar strikeout for space. Two years ago, the company's first moonshot ended in a crash landing, giving rise to the name 'Resilience' for its successor lander. Resilience carried a rover with a shovel to gather lunar dirt as well as a Swedish artist's toy-size red house for placement on the moon's dusty surface. Company officials said it was too soon to know whether the same problem doomed both missions. 'This is the second time that we were not able to land. So we really have to take it very seriously,' Hakamada told reporters. He stressed that the company would press ahead with more lunar missions. A preliminary analysis indicates the laser system for measuring the altitude did not work as planned, and the lander descended too fast, officials said. 'Based on these circumstances, it is currently assumed that the lander likely performed a hard landing on the lunar surface,' the company said in a written statement. Long the province of governments, the moon became a target of private outfits in 2019, with more flops than wins along the way. Launched in January from Florida on a long, roundabout journey, Resilience entered lunar orbit last month. It shared a SpaceX ride with Firefly Aerospace's Blue Ghost, which reached the moon faster and became the first private entity to successfully land there in March. Another US company, Intuitive Machines, arrived at the moon a few days after Firefly. But the tall, spindly lander face-planted in a crater near the moon's south pole and was declared dead within hours. Resilience was targeting the top of the moon, a less treacherous place than the shadowy bottom. The ispace team chose a flat area with few boulders in Mare Frigoris or Sea of Cold, a long and narrow region full of craters and ancient lava flows that stretches across the near side's northern tier. Plans had called for the 2.3-metre resilience to beam back pictures within hours and for the lander to lower the piggybacking rover onto the lunar surface this weekend. Made of carbon fiber-reinforced plastic with four wheels, ispace's European-built rover — named Tenacious — sported a high-definition camera to scout out the area and a shovel to scoop up some lunar dirt for NASA. The rover, weighing just 5 kilograms, was going to stick close to the lander, going in circles at a speed of less than one inch a couple centimeters per second. It was capable of venturing up to two-thirds of 1 kilometer from the lander and should be operational throughout the two-week mission, the period of daylight. Besides science and tech experiments, there was an artistic touch. The rover held a tiny, Swedish-style red cottage with white trim and a green door, dubbed the Moonhouse by creator Mikael Genberg, for placement on the lunar surface. Minutes before the attempted landing, Hakamada assured everyone that ispace had learned from its first failed mission. 'Engineers did everything they possibly could' to ensure success this time, he said. He considered the latest moonshot 'merely a steppingstone' to its bigger lander launching by 2027 with NASA involvement. Ispace, like other businesses, does not have 'infinite funds' and cannot afford repeated failures, Jeremy Fix, chief engineer for ispace's US subsidiary, said at a conference last month. While not divulging the cost of the current mission, company officials said it's less than the first one which exceeded $100 million. Two other US companies are aiming for moon landings by year's end: Jeff Bezos' Blue Origin and Astrobotic Technology. Astrobotic's first lunar lander missed the moon altogether in 2024 and came crashing back through Earth's atmosphere. For decades, governments competed to get to the moon. Only five countries have pulled off successful robotic lunar landings: Russia, the US, China, India and Japan. Of those, only the U.S. has landed people on the moon: 12 NASA astronauts from 1969 through 1972. NASA expects to send four astronauts around the moon next year. That would be followed a year or more later by the first lunar landing by a crew in more than a half-century, with SpaceX's Starship providing the lift from lunar orbit all the way down to the surface. China also has moon landing plans for its own astronauts by 2030.
The Hindu
3 days ago
- The Hindu
Europe suffers its largest diphtheria outbreak in 70 years
The largest diphtheria outbreak to strike Western Europe in 70 years has been affecting vulnerable people such as migrants and the homeless since 2022, new research said Wednesday. Diphtheria is a highly contagious bacterial infection that can attack the respiratory tract and spread throughout the body, causing a sore throat, fever and other symptoms. For unvaccinated people, it can be fatal in around 30 percent of cases, and is deadlier for children, according to the World Health Organization. In 2022, there was an unusual surge in the bacteria that causes diphtheria -- Corynebacterium diphtheriae -- in several European countries, particularly among recently arrived migrants, according to a study in the New England Journal of Medicine. That year 362 cases were recorded by the European Centre for Disease Prevention and Control. Contact tracing and screening helped tamp down the outbreak, but rare infections have continued to be recorded, the researchers said. A total of 536 cases, including three deaths, have been recorded across Europe since the start of 2022. Patient samples from 10 countries showed that 98 percent of the cases were in males with an average age of 18. Almost all had recently migrated. "The outbreak, which mainly affected migrants from Afghanistan and Syria, was not the result of people being infected in their countries of origin, but during their migration journeys or in their places of accommodation in European countries," said a joint statement from France's public health agency and the Pasteur Institute. The genetic similarities between the strains seen in people from different countries suggests that there was a "recent point of contact, outside the country of origin" at the source of the outbreak, the statement added. The exact areas affected by the outbreak remains unclear. But a genetic link between the 2022 strain and the one detected in Germany this year indicates that "the bacteria continues to circulate quietly in Western Europe," the statement said. Vaccination is very effective at fending off diphtheria, and the researchers emphasised the importance of immunisation programmes for the general public. They also called for European nations to do more to ensure their most vulnerable people avoid contracting the disease. That included raising awareness of the symptoms among doctors and those in contact with migrants and the homeless, as well as increasing access to vaccines and antibiotic drugs.
Time of India
3 days ago
- Time of India
Secret leprosy infected the Americas before European arrival
Representative image (AP) What to know: Leprosy is one of the oldest human diseases and originated in Eurasia or Africa A new study has found a different species of leprosy-causing bacteria existed in the Americas before European settlement. Scientists once believed Europeans brought leprosy to the American continents via infection from the bacterial species Mycobacterium leprae. But now a new study published in the journal Science reveals that a different form of leprosy-causing bacteria — called Mycobacterium lepromatosis — was already circulating in the Americas for at least one thousand years. Leprosy was therefore already affecting American indigenous peoples well before European colonization. Mycobacterium lepromatosis in America The study authors analyzed more than 800 samples taken from ancient remains in Canada and Argentina. The genomes of the bacteria taken from the samples were reconstructed, analyzed, and dated. Comparisons between the samples showed the bacterial genomes were of distinctive branches of the lepromatosis species at each end of the continent. However, they remained genetically similar. This suggested that the bacteria species had spread rapidly across the Americas, probably covering the landmass in just a few hundred years. Leprosy is caused by two bacteria species, not one. Leprosy is an ancient disease Leprosy has been infecting humans for thousands of years. The disease presents as multiple numbing skin lesions. If left untreated, it can result in nerve damage, muscle weakness, paralysis and blindness. Today, leprosy can be treated with antibiotics, but ancient sufferers weren't so fortunate. Skeletal records from 2,000BCE have been found in India with traces of the disease caused by Mycobacterium leprae. These are matched by written records of leprosy cases in ancient literature from Indian, Chinese and African civilizations, as well as stories in the Abrahamic religions. Often, these ancient descriptions associated the affliction with stigmas of immorality or ritual uncleanliness. But in 1874 the Norwegian doctor Gerhard Armauer Hansen discovered that leprosy was caused by the microscopic organism Mycobacterium leprae. In 2008, doctors in Mexico found another leprosy-causing bacteria species — Mycobacterium lepromatosis — in a leprosy patient. Before this, it was believed leprae was the only pathogen capable of causing the disease. Now both forms of the bacteria are known to cause it. Europeans spread diseases, leprosy too Nicolas Rascovan, head of the Microbial Paleogenomics Unit at the Pasteur Institut in France led the investigation. He and his colleagues estimate lepromatosis and leprae diverged from a common ancestor about one million years ago. "The diversification happened probably independent of humans," Rascovan told DW. The arrival of the first European fleets to the Americas in 1492 marked the introduction of new diseases to the Americas. Leprosy — in the form of the leprae bacterium — was among them. Archaeological evidence has shown leprae migrated with human groups out of Africa and into Asia and Europe around 40,000 years ago. Its introduction to the Americas, along with other diseases, by Europeans devastated indigenous communities and intensified the impact of pathogens that were already circulating before colonization. The discovery of lepromatosis' longer history on the continent further highlights the diversity of pathogens and their complex relationship with humans throughout history, said Rascovan. "Europeans had a very important impact by bringing this new species [leprae] that was absent in America," he said. Leprosy track and trace Rascovan hopes the presence of lepromatosis in the archeological record will improve understanding of pre-colonial disease, especially in the absence of written records. In addition, the study helps understand modern cases of leprosy, especially how it could make the jump from animals like squirrels to humans. "Our work is giving the kick start to really start analyzing, monitoring and understanding the diversity of natural reservoirs [disease carriers]," said Rascovan. He said monitoring the disease and preventing spillovers from animals to humans should be a priority. The disease is still prevalent today — 200,000 cases are reported each year globally. Brazil, India and Indonesia still report more than 10,000 new cases annually, according to WHO data.
